T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XHR
1926
Xenia Hotels & Resorts
XHR
$1.73B
| $1.32M | ﹤0.01% |
96,223
+2,037
| +2% | +$27.7K |
|
1927
Center Bancorp
CNOB
$1.81B
| $1.32M | ﹤0.01% |
53,097
+2,171
| +4% | +$53.5K |
|
1928
Sylvamo
SLVM
$1.53B
| $1.32M | ﹤0.01% |
29,746
+1,426
| +5% | +$66.1K |
|
1929
Dime Commercial Bancshares
DCOM
$1.81B
| $1.31M | ﹤0.01% |
44,035
+1,769
| +4% | +$51.9K |
|
1930
Middlesex Water
MSEX
$1.11B
| $1.31M | ﹤0.01% |
24,256
+1,746
| +8% | +$93.4K |
|
1931
Dave Inc
DAVE
$4.26B
| $1.31M | ﹤0.01% |
6,566
+1,935
| +42% | +$418K |
|
1932
Digi International
DGII
$3.23B
| $1.31M | ﹤0.01% |
35,872
+1,694
| +5% | +$58.2K |
|
1933
Burford Capital
BUR
$968M
| $1.29M | ﹤0.01% |
107,764
+11,713
| +12% | +$157K |
|
1934
Cogent Biosciences
COGT
$6.47B
| $1.29M | ﹤0.01% |
89,716
+16,564
| +23% | +$196K |
|
1935
Pacira BioSciences
PCRX
$924M
| $1.29M | ﹤0.01% |
49,981
+2,071
| +4% | +$50.9K |
|
1936
Fidelity MSCI Health Care Index ETF
FHLC
$3.42B
| $1.29M | ﹤0.01% |
19,230
+15
| +0.1% | +$969 |
|
1937
NETGEAR
NTGR
$658M
| $1.28M | ﹤0.01% |
39,645
+629
| +2% | +$17.2K |
|
|
ARR
1938
Armour Residential REIT
ARR
$2.37B
| $1.28M | ﹤0.01% |
85,915
+24,210
| +39% | +$380K |
|
1939
Freedom Holding
FRHC
$9.65B
| $1.28M | ﹤0.01% |
7,449
+930
| +14% | +$157K |
|
1940
Barrett Business Services
BBSI
$800M
| $1.28M | ﹤0.01% |
28,861
-34,523
| -54% | -$1.58M |
|
1941
Univest Financial
UVSP
$1.18B
| $1.27M | ﹤0.01% |
42,403
+1,771
| +4% | +$54.4K |
|
|
ETNB
1942
DELISTED
89bio
ETNB
| $1.27M | ﹤0.01% |
86,256
+6,227
| +8% | +$63.5K |
|
1943
OceanFirst Financial
OCFC
$1.88B
| $1.27M | ﹤0.01% |
72,058
-82,697
| -53% | -$1.48M |
|
1944
Alphatec Holdings
ATEC
$1.51B
| $1.26M | ﹤0.01% |
86,997
+8,601
| +11% | +$120K |
|
1945
Prelude Therapeutics
PRLD
$428M
| $1.26M | ﹤0.01% |
876,338
-51,270
| -6% | -$51.4K |
|
1946
Astec Industries
ASTE
$994M
| $1.26M | ﹤0.01% |
26,125
+870
| +3% | +$38K |
|
1947
Ardelyx
ARDX
$1.01B
| $1.25M | ﹤0.01% |
227,320
+20,069
| +10% | +$109K |
|
|
VRNT
1948
DELISTED
Verint Systems
VRNT
| $1.25M | ﹤0.01% |
61,844
+952
| +2% | +$19.6K |
|
|
STEL
1949
DELISTED
Stellar Bancorp
STEL
| $1.25M | ﹤0.01% |
41,112
+901
| +2% | +$27.4K |
|
1950
iShares Russell 1000 Value ETF
IWD
$84.3B
| $1.25M | ﹤0.01% |
6,124
-427
| -7% | -$84.9K |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.